{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:37Z","timestamp":1789609117297,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis Supplements"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.atherosclerosissup.2012.10.025","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T12:33:41Z","timestamp":1359203621000},"page":"167-173","source":"Crossref","is-referenced-by-count":46,"title":["Immunoadsorption in steroid-refractory multiple sclerosis: Clinical experience in 60 patients"],"prefix":"10.1016","volume":"14","author":[{"given":"Franz","family":"Heigl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Hettich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Durner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Mauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2008-1040881","article-title":"The natural history of multiple sclerosis: update 1998","volume":"18","author":"Weinshenker","year":"1998","journal-title":"Semin Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis \u2013 the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00115-006-2220-x","article-title":"Immunmodulatorische Stufentherapie der Multiplen Sklerose. Aktuelle Therapieempfehlungen (September 2006)","volume":"77","author":"Multiple Sklerose Therapie Konsensus Gruppe (MSTKG)","year":"2006","journal-title":"Nervenarzt"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00415-008-0061-1","article-title":"Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations","volume":"255","author":"Multiple Sclerosis Therapy Consensus Group (MSTCG)","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib6","series-title":"Guidelines for diagnosis and therapy in neurology (Leitlinien f\u00fcr die Diagnostik und Therapie in der Neurologie)","year":"2008"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000138437.99046.6B","article-title":"Plasma exchange for severe optic neuritis: treatment of 10 patients","volume":"63","author":"Ruprecht","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00115-005-2019-1","article-title":"Plasmaaustausch bei steroidresistenten Multiple-Sklerose-Sch\u00fcben \u2013 Klinische Erfahrungen an 16 Patienten","volume":"77","author":"Schilling","year":"2006","journal-title":"Nervenarzt"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000224630","article-title":"Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis","volume":"28","author":"Trebst","year":"2009","journal-title":"Blood Purif"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0028-1090231","article-title":"Plasmapherese in der Eskalationstherapie der Multiplen Sklerose: Verlaufsbeobachtung an 35 Patienten","volume":"36","author":"Schr\u00f6der","year":"2009","journal-title":"Akt Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000332397","article-title":"Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis","volume":"33","author":"Trebst","year":"2012","journal-title":"Blood Purif"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0032-1305029","article-title":"Immunadsorption zur Eskalation der Schubtherapie bei Multipler Sklerose","volume":"39","author":"Schimrigk","year":"2012","journal-title":"Akt Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-9-80","article-title":"Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis","volume":"9","author":"Koziolek","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clineuro.2004.12.019","article-title":"Factors influencing outcome in Guillain-Barr\u00e9 syndrome: comparison of plasma adsorption against other treatments","volume":"107","author":"Seta","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12028-009-9252-6","article-title":"Selective immune adsorption treatment of severe Guillain Barr\u00e9 Syndrome in the intensive care unit","volume":"11","author":"Galldiks","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jca.20317","article-title":"A randomised and controlled clinical study comparing immunoadsorption and plasma exchange in myasthenic crisis","volume":"26","author":"K\u00f6hler","year":"2011","journal-title":"J Clin Apher"},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosissup.2012.10.025_bib19","first-page":"A427","article-title":"Efficacy and safety of immunoadsorption vs plasmapheresis vs combination for treatment of myasthenic crisis: comparative retrospective study on 72 patients","volume":"70","author":"Gold","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.atherosclerosissup.2012.10.025_bib20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.atherosclerosissup.2012.10.025_bib21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00115-011-3324-5","article-title":"Immunadsorption bei steroidrefrakt\u00e4rem Schub der Multiplen Sklerose","volume":"82","author":"Mauch","year":"2011","journal-title":"Nervenarzt"},{"issue":"5","key":"10.1016\/j.atherosclerosissup.2012.10.025_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1567-5688(09)71827-6","article-title":"Plasma exchange and immunoadsorption for autoimmune neurologic diseases \u2013 current guidelines and future perspectives","volume":"10","author":"Klingel","year":"2009","journal-title":"Atheroscler Suppl"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.025_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2990.2006.00781.x","article-title":"Persistent endothelial abnormalities and blood\u2013brain barrier leak in primary and secondary progressive multiple sclerosis","volume":"33","author":"Leech","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","article-title":"Treatment of myasthenia gravis by immunoadsorption of plasma","volume":"45","author":"Grob","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2007-1018024","article-title":"Immunadsorption bei Myasthenia gravis. Wirkungsweise, immunologische Parameter und klinischer Verlauf","volume":"20","author":"Bucka","year":"1993","journal-title":"Akt Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00002480-198907000-00131","article-title":"Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis","volume":"35","author":"Hosokawa","year":"1989","journal-title":"ASAIO Trans"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.025_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1525-1594.2002.06920.x","article-title":"Changes in lymphocytic cluster distribution during extracorporeal immunoadsorption","volume":"26","author":"Schneidewind-M\u00fcller","year":"2002","journal-title":"Artif Organs"},{"key":"10.1016\/j.atherosclerosissup.2012.10.025_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1474-4422(08)70281-3","article-title":"New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab","volume":"8","author":"Hartung","year":"2009","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.025_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/ajkd.2002.30564","article-title":"Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis","volume":"39","author":"Schmaldienst","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["Atherosclerosis Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568812000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568812000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T01:32:11Z","timestamp":1539912731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567568812000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1567568812000360"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2012.10.025","relation":{},"ISSN":["1567-5688"],"issn-type":[{"value":"1567-5688","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}